Cite
APA Citation
Cho, B. C., Yoh, K., Bar, J., Nagrial, A., Spigel, D. R., Gutierrez, M., Kim, D., Kotasek, D., Rasco, D., Niu, J., Satouchi, M., Ahn, M., Lee, D. H., Maurice-Dror, C., Siddiqi, S., Li, X., Cyrus, J., Altura, R. A., & Perets, R. (n.d.). 98P Results from a phase I study of MK-1308 (anti–CTLA-4) plus pembrolizumab in previously treated advanced small cell lung cancer. Annals of oncology, 30, . http://access.bl.uk/ark:/81055/vdc_100099397464.0x000029